corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 237

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Warlow C, Sandercock P, Dennis M, Wardlaw J.
Research funding.
Lancet 1999 Jun 26; 353:(9171):2250


Abstract:

There is also a bias in industry funded trials on stroke. There is evidence that pharmaceutical industry involvement increases the delay in publication of negative studies. Clinicans who work on industry sponsored trials have less time available to work on noncommercial trials. Ethics committees should insist on absolute transparency of the amount of invovlement by commercial sponsors in trials submitted for their approval.

Keywords:
*letter to the editor clinical trials drug company sponsored research reporting of results relationship between researchers, academic institutions and industry corporate funding ETHICAL ISSUES IN PROMOTION: LINKS BETWEEN HEALTH PROFESSIONALS AND INDUSTRY INFLUENCE OF PROMOTION: OUTCOME OF CLINICAL TRIALS INFLUENCE OF PROMOTION: PUBLICATION SPONSORSHIP: RESEARCH

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.